Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine spray versus acupressure for pain from intramuscular injection
IRCT20180110038300N1Phase 3Completed
- Sponsor
- Sabzevar University of Medical Sciences
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of lidocaine in Intramuscular injection pain (3 arms), sponsored by Sabzevar University of Medical Sciences. Primary endpoint: Reduction in pain in patients. Started Jul 2019; status: completed.
02
Drugs
lidocaine
03
Conditions
Intramuscular injection pain
Beyond the preview
Go deeper on IRCT20180110038300N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180110038300N1.